The Food and Drug Administration (FDA) is investigating an allergy to the Pfizer coronovirus vaccine that was reported in several states after it began this week.
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, told reporters late Friday that reactions have been reported in more than one state other than Alaska and that the FDA is investigating five responses.
“We are working with the Centers for Disease Control and Prevention (CDC), and we are actually working closely with our United Kingdom colleagues who reported an allergic reaction in due course. I think we can look at all the data derived from each of these responses to see what really happened, and we will try to understand which components of the vaccine can help to make them. said.
“I think we have it right at this point … a mitigation strategy is in place with the availability of treatment for a severe allergic reaction, and we will continue to monitor it very closely,” he said.
Marks said the FDA was not sure what caused the reactions, but indicated a chemical called polyethylene glycol, which is present in vaccines produced by Pfizer and BioNotech, as well as “may be the culprit” by Modern. He said that the reaction some people have experienced may be more general than one-time thought.
“We will obviously monitor very closely what is happening. We are working closely with the CDC on these, and every week this week there have been a lot of meetings between the CDC and the FDA, making sure that we are tracking very closely what is going on.
Reports of allergic reactions in Alaska follow two cases reported last week in Britain, the first country to approve a Pfizer vaccine.
Current FDA guidance states that most Americans with allergies should be approved to take the vaccine, but those who had severe reactions to other vaccines should not be vaccinated. It also said on Friday that people with a history of severe allergic reactions to any component of the modern shot should avoid receiving that vaccine.
“The FDA takes the safety of medical products very seriously that we authorize and approve, and certainly in the vaccine setting, this is one of the reasons why Dr. Marks and his team teamed up with the CDC for a very Has established a robust monitoring system. To assess safety. FDA is very well and uniquely reaching the bottom of events, allowing us to fully understand the circumstances and better address the public and its regulatory decisions. Can also be reported to the FDA, ” said the FDA Commissioner Stephen hanStephen Hain Hill’s Morning Report – Presented by MasterCard – COVID-19 Relief, Omnibus Talks Down on the Wire Hill’s Morning Report – Presented by MasterCard – Congress Shows Slogan Towards COVID-19 Relief, Omnibus Deal FDA First Completely From home, fully over-the-counter authorized COVID-19 test and.